AnPac Bio-Medical Science Co., Ltd. Sees Large Drop in Short Interest
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
About 62% of Anpac Bio's investor base is looking to short. The analysis of current outlook of investing in Anpac Bio Medical suggests that many traders are alarmed regarding Anpac Bio's prospects. The current market sentiment, together with Anpac Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Anpac Bio Medical stock news signals to limit their universe of possible portfolio assets.
Anpac |
AnPac Bio-Medical Science Co., Ltd. saw a large drop in short interest in January. As of January 15th, there was short interest totalling 90,300 shares, a drop of 28.2 percent from the December 31st total of 125,700 shares. Based on an average daily volume of 41,300 shares, the short-interest ratio is currently
Read at thelincolnianonline.com
 |
Anpac Bio Fundamental Analysis
We analyze Anpac Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Anpac Bio is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Anpac Bio Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anpac Bio stock to make a market-neutral strategy. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics with similar companies.
Peers
Anpac Bio Related Equities
| ANTX | AN2 Therapeutics | 21.90 | ||||
| OPT | Opthea | 10.81 | ||||
| MRKR | Marker Therapeutics | 9.72 | ||||
| CCCC | C4 Therapeutics | 8.59 | ||||
| ALRN | Aileron Therapeutics | 4.38 | ||||
| ABVC | ABVC Biopharma | 3.92 | ||||
| EWTX | Edgewise Therapeutics | 2.48 | ||||
| HOWL | Werewolf Therapeutics | 1.52 | ||||
| PMVP | Pmv Pharmaceuticals | 1.25 | ||||
| ACRV | Acrivon Therapeutics, | 0.80 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| AVTE | Aerovate Therapeutics | 0.38 | ||||
| CELC | Celcuity LLC | 0.39 | ||||
| LUMO | Lumos Pharma | 0.46 | ||||
| PTIX | Protagenic Therapeutics | 1.67 | ||||
| XCUR | Exicure | 7.81 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |